Global Cancer Genomic Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 196459
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Cancer Genomic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cancer Genomic Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cancer Genomic Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Cancer Genomic Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Breast Cancer Genomic Testing

Lung Cancer Genomic Testing

Blood Cancer Genomic Testing

Liver Cancer Genomic Testing

Stomach Cancer Genomic Testing

Others

Market segment by Application, can be divided into

Hospitals

Clinics

Diagnostic Laboratories

Academic and Research Institutes

Others

Market segment by players, this report covers

Myriad Genetics

Centogene AG

Color Genomics

Quest Diagnostics

23andMe Inc.

Gene By Gene Ltd.

LabCorp

Positive Bioscience

Bio-Rad Laboratories

Illumina, Inc.

Agilent Technologies

Thermo Fisher Scientific

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Cancer Genomic Testing

1.2 Classification of Cancer Genomic Testing by Type

1.2.1 Overview: Global Cancer Genomic Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Cancer Genomic Testing Revenue Market Share by Type in 2020

1.2.3 Breast Cancer Genomic Testing

1.2.4 Lung Cancer Genomic Testing

1.2.5 Blood Cancer Genomic Testing

1.2.6 Liver Cancer Genomic Testing

1.2.7 Stomach Cancer Genomic Testing

1.2.8 Others

1.3 Global Cancer Genomic Testing Market by Application

1.3.1 Overview: Global Cancer Genomic Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Diagnostic Laboratories

1.3.5 Academic and Research Institutes

1.3.6 Others

1.4 Global Cancer Genomic Testing Market Size & Forecast

1.5 Global Cancer Genomic Testing Market Size and Forecast by Region

1.5.1 Global Cancer Genomic Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Cancer Genomic Testing Market Size by Region, (2016-2021)

1.5.3 North America Cancer Genomic Testing Market Size and Prospect (2016-2026)

1.5.4 Europe Cancer Genomic Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Cancer Genomic Testing Market Size and Prospect (2016-2026)

1.5.6 South America Cancer Genomic Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Cancer Genomic Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Cancer Genomic Testing Market Drivers

1.6.2 Cancer Genomic Testing Market Restraints

1.6.3 Cancer Genomic Testing Trends Analysis

2 Company Profiles

2.1 Myriad Genetics

2.1.1 Myriad Genetics Details

2.1.2 Myriad Genetics Major Business

2.1.3 Myriad Genetics Cancer Genomic Testing Product and Solutions

2.1.4 Myriad Genetics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Myriad Genetics Recent Developments and Future Plans

2.2 Centogene AG

2.2.1 Centogene AG Details

2.2.2 Centogene AG Major Business

2.2.3 Centogene AG Cancer Genomic Testing Product and Solutions

2.2.4 Centogene AG Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Centogene AG Recent Developments and Future Plans

2.3 Color Genomics

2.3.1 Color Genomics Details

2.3.2 Color Genomics Major Business

2.3.3 Color Genomics Cancer Genomic Testing Product and Solutions

2.3.4 Color Genomics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Color Genomics Recent Developments and Future Plans

2.4 Quest Diagnostics

2.4.1 Quest Diagnostics Details

2.4.2 Quest Diagnostics Major Business

2.4.3 Quest Diagnostics Cancer Genomic Testing Product and Solutions

2.4.4 Quest Diagnostics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Quest Diagnostics Recent Developments and Future Plans

2.5 23andMe Inc.

2.5.1 23andMe Inc. Details

2.5.2 23andMe Inc. Major Business

2.5.3 23andMe Inc. Cancer Genomic Testing Product and Solutions

2.5.4 23andMe Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 23andMe Inc. Recent Developments and Future Plans

2.6 Gene By Gene Ltd.

2.6.1 Gene By Gene Ltd. Details

2.6.2 Gene By Gene Ltd. Major Business

2.6.3 Gene By Gene Ltd. Cancer Genomic Testing Product and Solutions

2.6.4 Gene By Gene Ltd. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Gene By Gene Ltd. Recent Developments and Future Plans

2.7 LabCorp

2.7.1 LabCorp Details

2.7.2 LabCorp Major Business

2.7.3 LabCorp Cancer Genomic Testing Product and Solutions

2.7.4 LabCorp Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 LabCorp Recent Developments and Future Plans

2.8 Positive Bioscience

2.8.1 Positive Bioscience Details

2.8.2 Positive Bioscience Major Business

2.8.3 Positive Bioscience Cancer Genomic Testing Product and Solutions

2.8.4 Positive Bioscience Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Positive Bioscience Recent Developments and Future Plans

2.9 Bio-Rad Laboratories

2.9.1 Bio-Rad Laboratories Details

2.9.2 Bio-Rad Laboratories Major Business

2.9.3 Bio-Rad Laboratories Cancer Genomic Testing Product and Solutions

2.9.4 Bio-Rad Laboratories Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Bio-Rad Laboratories Recent Developments and Future Plans

2.10 Illumina, Inc.

2.10.1 Illumina, Inc. Details

2.10.2 Illumina, Inc. Major Business

2.10.3 Illumina, Inc. Cancer Genomic Testing Product and Solutions

2.10.4 Illumina, Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Illumina, Inc. Recent Developments and Future Plans

2.11 Agilent Technologies

2.11.1 Agilent Technologies Details

2.11.2 Agilent Technologies Major Business

2.11.3 Agilent Technologies Cancer Genomic Testing Product and Solutions

2.11.4 Agilent Technologies Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Agilent Technologies Recent Developments and Future Plans

2.12 Thermo Fisher Scientific

2.12.1 Thermo Fisher Scientific Details

2.12.2 Thermo Fisher Scientific Major Business

2.12.3 Thermo Fisher Scientific Cancer Genomic Testing Product and Solutions

2.12.4 Thermo Fisher Scientific Cancer Genomic Testing Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Thermo Fisher Scientific Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Cancer Genomic Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Cancer Genomic Testing Players Market Share

3.2.2 Top 10 Cancer Genomic Testing Players Market Share

3.2.3 Market Competition Trend

3.3 Cancer Genomic Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Cancer Genomic Testing Revenue and Market Share by Type (2016-2021)

4.2 Global Cancer Genomic Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Cancer Genomic Testing Revenue Market Share by Application (2016-2021)

5.2 Cancer Genomic Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Cancer Genomic Testing Revenue by Type (2016-2026)

6.2 North America Cancer Genomic Testing Revenue by Application (2016-2026)

6.3 North America Cancer Genomic Testing Market Size by Country

6.3.1 North America Cancer Genomic Testing Revenue by Country (2016-2026)

6.3.2 United States Cancer Genomic Testing Market Size and Forecast (2016-2026)

6.3.3 Canada Cancer Genomic Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico Cancer Genomic Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Cancer Genomic Testing Revenue by Type (2016-2026)

7.2 Europe Cancer Genomic Testing Revenue by Application (2016-2026)

7.3 Europe Cancer Genomic Testing Market Size by Country

7.3.1 Europe Cancer Genomic Testing Revenue by Country (2016-2026)

7.3.2 Germany Cancer Genomic Testing Market Size and Forecast (2016-2026)

7.3.3 France Cancer Genomic Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Cancer Genomic Testing Market Size and Forecast (2016-2026)

7.3.5 Russia Cancer Genomic Testing Market Size and Forecast (2016-2026)

7.3.6 Italy Cancer Genomic Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Cancer Genomic Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific Cancer Genomic Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific Cancer Genomic Testing Market Size by Region

8.3.1 Asia-Pacific Cancer Genomic Testing Revenue by Region (2016-2026)

8.3.2 China Cancer Genomic Testing Market Size and Forecast (2016-2026)

8.3.3 Japan Cancer Genomic Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea Cancer Genomic Testing Market Size and Forecast (2016-2026)

8.3.5 India Cancer Genomic Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Cancer Genomic Testing Market Size and Forecast (2016-2026)

8.3.7 Australia Cancer Genomic Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Cancer Genomic Testing Revenue by Type (2016-2026)

9.2 South America Cancer Genomic Testing Revenue by Application (2016-2026)

9.3 South America Cancer Genomic Testing Market Size by Country

9.3.1 South America Cancer Genomic Testing Revenue by Country (2016-2026)

9.3.2 Brazil Cancer Genomic Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina Cancer Genomic Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Cancer Genomic Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa Cancer Genomic Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa Cancer Genomic Testing Market Size by Country

10.3.1 Middle East & Africa Cancer Genomic Testing Revenue by Country (2016-2026)

10.3.2 Turkey Cancer Genomic Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Cancer Genomic Testing Market Size and Forecast (2016-2026)

10.3.4 UAE Cancer Genomic Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Cancer Genomic Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Cancer Genomic Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Cancer Genomic Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Cancer Genomic Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Cancer Genomic Testing Revenue Market Share by Region (2021-2026)

Table 6. Myriad Genetics Corporate Information, Head Office, and Major Competitors

Table 7. Myriad Genetics Major Business

Table 8. Myriad Genetics Cancer Genomic Testing Product and Solutions

Table 9. Myriad Genetics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Centogene AG Corporate Information, Head Office, and Major Competitors

Table 11. Centogene AG Major Business

Table 12. Centogene AG Cancer Genomic Testing Product and Solutions

Table 13. Centogene AG Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Color Genomics Corporate Information, Head Office, and Major Competitors

Table 15. Color Genomics Major Business

Table 16. Color Genomics Cancer Genomic Testing Product and Solutions

Table 17. Color Genomics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Quest Diagnostics Corporate Information, Head Office, and Major Competitors

Table 19. Quest Diagnostics Major Business

Table 20. Quest Diagnostics Cancer Genomic Testing Product and Solutions

Table 21. Quest Diagnostics Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. 23andMe Inc. Corporate Information, Head Office, and Major Competitors

Table 23. 23andMe Inc. Major Business

Table 24. 23andMe Inc. Cancer Genomic Testing Product and Solutions

Table 25. 23andMe Inc. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Gene By Gene Ltd. Corporate Information, Head Office, and Major Competitors

Table 27. Gene By Gene Ltd. Major Business

Table 28. Gene By Gene Ltd. Cancer Genomic Testing Product and Solutions

Table 29. Gene By Gene Ltd. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. LabCorp Corporate Information, Head Office, and Major Competitors

Table 31. LabCorp Major Business

Table 32. LabCorp Cancer Genomic Testing Product and Solutions

Table 33. LabCorp Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Positive Bioscience Corporate Information, Head Office, and Major Competitors

Table 35. Positive Bioscience Major Business

Table 36. Positive Bioscience Cancer Genomic Testing Product and Solutions

Table 37. Positive Bioscience Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Bio-Rad Laboratories Corporate Information, Head Office, and Major Competitors

Table 39. Bio-Rad Laboratories Major Business

Table 40. Bio-Rad Laboratories Cancer Genomic Testing Product and Solutions

Table 41. Bio-Rad Laboratories Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Illumina, Inc. Corporate Information, Head Office, and Major Competitors

Table 43. Illumina, Inc. Major Business

Table 44. Illumina, Inc. Cancer Genomic Testing Product and Solutions

Table 45. Illumina, Inc. Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Agilent Technologies Corporate Information, Head Office, and Major Competitors

Table 47. Agilent Technologies Major Business

Table 48. Agilent Technologies Cancer Genomic Testing Product and Solutions

Table 49. Agilent Technologies Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 51. Thermo Fisher Scientific Major Business

Table 52. Thermo Fisher Scientific Cancer Genomic Testing Product and Solutions

Table 53. Thermo Fisher Scientific Cancer Genomic Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Global Cancer Genomic Testing Revenue (USD Million) by Players (2019-2021)

Table 55. Global Cancer Genomic Testing Revenue Share by Players (2019-2021)

Table 56. Breakdown of Cancer Genomic Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 57. Cancer Genomic Testing Players Head Office, Products and Services Provided

Table 58. Cancer Genomic Testing Mergers & Acquisitions in the Past Five Years

Table 59. Cancer Genomic Testing New Entrants and Expansion Plans

Table 60. Global Cancer Genomic Testing Revenue (USD Million) by Type (2016-2021)

Table 61. Global Cancer Genomic Testing Revenue Share by Type (2016-2021)

Table 62. Global Cancer Genomic Testing Revenue Forecast by Type (2021-2026)

Table 63. Global Cancer Genomic Testing Revenue by Application (2016-2021)

Table 64. Global Cancer Genomic Testing Revenue Forecast by Application (2021-2026)

Table 65. North America Cancer Genomic Testing Revenue by Type (2016-2021) & (USD Million)

Table 66. North America Cancer Genomic Testing Revenue by Type (2021-2026) & (USD Million)

Table 67. North America Cancer Genomic Testing Revenue by Application (2016-2021) & (USD Million)

Table 68. North America Cancer Genomic Testing Revenue by Application (2021-2026) & (USD Million)

Table 69. North America Cancer Genomic Testing Revenue by Country (2016-2021) & (USD Million)

Table 70. North America Cancer Genomic Testing Revenue by Country (2021-2026) & (USD Million)

Table 71. Europe Cancer Genomic Testing Revenue by Type (2016-2021) & (USD Million)

Table 72. Europe Cancer Genomic Testing Revenue by Type (2021-2026) & (USD Million)

Table 73. Europe Cancer Genomic Testing Revenue by Application (2016-2021) & (USD Million)

Table 74. Europe Cancer Genomic Testing Revenue by Application (2021-2026) & (USD Million)

Table 75. Europe Cancer Genomic Testing Revenue by Country (2016-2021) & (USD Million)

Table 76. Europe Cancer Genomic Testing Revenue by Country (2021-2026) & (USD Million)

Table 77. Asia-Pacific Cancer Genomic Testing Revenue by Type (2016-2021) & (USD Million)

Table 78. Asia-Pacific Cancer Genomic Testing Revenue by Type (2021-2026) & (USD Million)

Table 79. Asia-Pacific Cancer Genomic Testing Revenue by Application (2016-2021) & (USD Million)

Table 80. Asia-Pacific Cancer Genomic Testing Revenue by Application (2021-2026) & (USD Million)

Table 81. Asia-Pacific Cancer Genomic Testing Revenue by Region (2016-2021) & (USD Million)

Table 82. Asia-Pacific Cancer Genomic Testing Revenue by Region (2021-2026) & (USD Million)

Table 83. South America Cancer Genomic Testing Revenue by Type (2016-2021) & (USD Million)

Table 84. South America Cancer Genomic Testing Revenue by Type (2021-2026) & (USD Million)

Table 85. South America Cancer Genomic Testing Revenue by Application (2016-2021) & (USD Million)

Table 86. South America Cancer Genomic Testing Revenue by Application (2021-2026) & (USD Million)

Table 87. South America Cancer Genomic Testing Revenue by Country (2016-2021) & (USD Million)

Table 88. South America Cancer Genomic Testing Revenue by Country (2021-2026) & (USD Million)

Table 89. Middle East & Africa Cancer Genomic Testing Revenue by Type (2016-2021) & (USD Million)

Table 90. Middle East & Africa Cancer Genomic Testing Revenue by Type (2021-2026) & (USD Million)

Table 91. Middle East & Africa Cancer Genomic Testing Revenue by Application (2016-2021) & (USD Million)

Table 92. Middle East & Africa Cancer Genomic Testing Revenue by Application (2021-2026) & (USD Million)

Table 93. Middle East & Africa Cancer Genomic Testing Revenue by Country (2016-2021) & (USD Million)

Table 94. Middle East & Africa Cancer Genomic Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Cancer Genomic Testing Picture

Figure 2. Global Cancer Genomic Testing Revenue Market Share by Type in 2020

Figure 3. Breast Cancer Genomic Testing

Figure 4. Lung Cancer Genomic Testing

Figure 5. Blood Cancer Genomic Testing

Figure 6. Liver Cancer Genomic Testing

Figure 7. Stomach Cancer Genomic Testing

Figure 8. Others

Figure 9. Cancer Genomic Testing Revenue Market Share by Application in 2020

Figure 10. Hospitals Picture

Figure 11. Clinics Picture

Figure 12. Diagnostic Laboratories Picture

Figure 13. Academic and Research Institutes Picture

Figure 14. Others Picture

Figure 15. Global Cancer Genomic Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 16. Global Cancer Genomic Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 17. Global Cancer Genomic Testing Revenue Market Share by Region (2016-2026)

Figure 18. Global Cancer Genomic Testing Revenue Market Share by Region in 2020

Figure 19. North America Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Europe Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Asia-Pacific Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. South America Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Middle East and Africa Cancer Genomic Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Cancer Genomic Testing Market Drivers

Figure 25. Cancer Genomic Testing Market Restraints

Figure 26. Cancer Genomic Testing Market Trends

Figure 27. Myriad Genetics Recent Developments and Future Plans

Figure 28. Centogene AG Recent Developments and Future Plans

Figure 29. Color Genomics Recent Developments and Future Plans

Figure 30. Quest Diagnostics Recent Developments and Future Plans

Figure 31. 23andMe Inc. Recent Developments and Future Plans

Figure 32. Gene By Gene Ltd. Recent Developments and Future Plans

Figure 33. LabCorp Recent Developments and Future Plans

Figure 34. Positive Bioscience Recent Developments and Future Plans

Figure 35. Bio-Rad Laboratories Recent Developments and Future Plans

Figure 36. Illumina, Inc. Recent Developments and Future Plans

Figure 37. Agilent Technologies Recent Developments and Future Plans

Figure 38. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 39. Global Cancer Genomic Testing Revenue Share by Players in 2020

Figure 40. Cancer Genomic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 41. Global Top 3 Players Cancer Genomic Testing Revenue Market Share in 2020

Figure 42. Global Top 10 Players Cancer Genomic Testing Revenue Market Share in 2020

Figure 43. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 44. Global Cancer Genomic Testing Revenue Share by Type in 2020

Figure 45. Global Cancer Genomic Testing Market Share Forecast by Type (2021-2026)

Figure 46. Global Cancer Genomic Testing Revenue Share by Application in 2020

Figure 47. Global Cancer Genomic Testing Market Share Forecast by Application (2021-2026)

Figure 48. North America Cancer Genomic Testing Sales Market Share by Type (2016-2026)

Figure 49. North America Cancer Genomic Testing Sales Market Share by Application (2016-2026)

Figure 50. North America Cancer Genomic Testing Revenue Market Share by Country (2016-2026)

Figure 51. United States Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Canada Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Mexico Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Europe Cancer Genomic Testing Sales Market Share by Type (2016-2026)

Figure 55. Europe Cancer Genomic Testing Sales Market Share by Application (2016-2026)

Figure 56. Europe Cancer Genomic Testing Revenue Market Share by Country (2016-2026)

Figure 57. Germany Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. France Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. United Kingdom Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Russia Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Italy Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Asia-Pacific Cancer Genomic Testing Sales Market Share by Type (2016-2026)

Figure 63. Asia-Pacific Cancer Genomic Testing Sales Market Share by Application (2016-2026)

Figure 64. Asia-Pacific Cancer Genomic Testing Revenue Market Share by Region (2016-2026)

Figure 65. China Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Japan Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. South Korea Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. India Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Southeast Asia Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Australia Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South America Cancer Genomic Testing Sales Market Share by Type (2016-2026)

Figure 72. South America Cancer Genomic Testing Sales Market Share by Application (2016-2026)

Figure 73. South America Cancer Genomic Testing Revenue Market Share by Country (2016-2026)

Figure 74. Brazil Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Argentina Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Middle East and Africa Cancer Genomic Testing Sales Market Share by Type (2016-2026)

Figure 77. Middle East and Africa Cancer Genomic Testing Sales Market Share by Application (2016-2026)

Figure 78. Middle East and Africa Cancer Genomic Testing Revenue Market Share by Country (2016-2026)

Figure 79. Turkey Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Saudi Arabia Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. UAE Cancer Genomic Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Methodology

Figure 83. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz